WHO Guidelines On Controlled Drugs

3 March 1997

The World Health Organization has begun distributing model guidelinesto its member states to facilitate donations of essential drugs containing narcotic or psychotropic substances to treat victims of disasters.

The guidelines will help national authorities simplify regulatory procedures for such donations, which currently make fast international transport of controlled drugs to emergency sites virtually impossible. They will allow selected suppliers of controlled drugs to make international shipments without prior export/import authorizations. Such shipment supplies are currently seen by control authorities as "exportation" requiring prior import documents from the recipient country. The WHO says this often takes too long to meet the urgent needs of relief work. As a result, all humanitarian aid agencies have abandoned the provision of narcotic drugs in their emergency medical supplies.

The new guidelines were drafted at a consultation convened by the WHO in September 1996 in Geneva. They were approved at the eighth International Consultation of Drug Regulatory Authorities in Bahrain in November 1996, which recommended their trial implementation.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight